Valcour Victor, Yee Priscilla, Williams Andrew E, Shiramizu Bruce, Watters Michael, Selnes Ola, Paul Robert, Shikuma Cecilia, Sacktor Ned
Hawaii AIDS Clinical Research Program, University of Hawaii, Honolulu, Hawaii, USA.
J Neurovirol. 2006 Oct;12(5):387-91. doi: 10.1080/13550280600915339.
Low CD4 lymphocyte count was a marker for neurological disease in human immunodeficiency virus type 1 (HIV-1); but is now less common among patients with access to highly active antiretroviral therapy. In this study, the authors determine the reliability of self-reported CD4 nadir and its predictive value for neurological status. The authors identify a high degree of reliability (r = .90). After adjusting for age, current CD4 count, and duration of HIV-1, CD4 nadir relates to a current diagnosis of HIV-associated dimentia (HAD) (odds ratio [OR]: 1.395 (1.106-1.761), P = .005) and distal symmetric polyneuropathy (DSPN) (OR: 1.479 (1.221-1.769, P < .001).
低CD4淋巴细胞计数曾是1型人类免疫缺陷病毒(HIV-1)神经疾病的一个标志物;但在能够获得高效抗逆转录病毒治疗的患者中,这种情况现在已不那么常见。在本研究中,作者们确定了自我报告的CD4最低点的可靠性及其对神经状态的预测价值。作者们发现其具有高度可靠性(r = 0.90)。在对年龄、当前CD4计数和HIV-1病程进行校正后,CD4最低点与当前HIV相关痴呆(HAD)诊断相关(比值比[OR]:1.395(1.106 - 1.761),P = 0.005)以及远端对称性多发性神经病(DSPN)相关(OR:1.479(1.221 - 1.769),P < 0.001)。